Literature DB >> 6132384

Acute transsynaptic regulation of tyrosine 3-monooxygenase activity in the rat superior cervical ganglion: evidence for both cholinergic and noncholinergic mechanisms.

N Y Ip, R L Perlman, R E Zigmond.   

Abstract

The rate of dopa synthesis in the rat superior cervical ganglion was increased 4- to 6-fold during continuous electrical stimulation of the cervical sympathetic trunk at 10 Hz for 30 min. This increase was only partially blocked by 3 mM hexamethonium and was not significantly affected by 6 microM atropine. In the presence of both hexamethonium and atropine, nerve stimulation still produced a 2- to 4-fold increase in dopa synthesis. Physostigmine increased dopa synthesis in both control and stimulated ganglia. This effect of physostigmine was completely blocked by hexamethonium and atropine. Dopa synthesis was also significantly increased when ganglia were incubated in a medium containing an elevated concentration of K+ (55 mM). This stimulatory effect of high K+ was totally dependent on the presence of Ca2+ in the medium, was decreased by 60% by prior decentralization of the ganglion, and was unaffected by hexamethonium and atropine. The data demonstrate that tyrosine hydroxylase activity is rapidly increased after preganglionic nerve stimulation and suggest that this increase is mediated in part by acetylcholine and in part by a second (noncholinergic) transmitter. The effects of an elevated K+ concentration may be mediated both by the release of a noncholinergic transmitter from the preganglionic nerve terminals and by direct depolarization of the ganglionic neurons.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132384      PMCID: PMC393757          DOI: 10.1073/pnas.80.7.2081

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Enhanced catecholamine synthesis in isolated rat superior cervical ganglia caused by nerve stimulation: dissociation between ganglionic transmission and catecholamine synthesis.

Authors:  M I Steinberg; C E Keller
Journal:  J Pharmacol Exp Ther       Date:  1978-02       Impact factor: 4.030

2.  A peptide as a possible transmitter in sympathetic ganglia of the frog.

Authors:  Y N Jan; L Y Jan; S W Kuffler
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

3.  Transmission blockade and stimulation of ganglionic adenylate cyclase by catecholamines.

Authors:  L Quenzer; D Yahn; K Alkadhi; R L Volle
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

Review 4.  Generation of slow inhibitory and excitatory postsynaptic potentials.

Authors:  B Libet
Journal:  Fed Proc       Date:  1970 Nov-Dec

5.  Early and late after discharges of amphibian sympathetic ganglion cells.

Authors:  S Nishi; K Koketsu
Journal:  J Neurophysiol       Date:  1968-01       Impact factor: 2.714

6.  The cyclic nucleotide content of the rat superior cervical ganglion.

Authors:  L F Quenzer; B A Patterson; R L Volle
Journal:  J Pharmacol Exp Ther       Date:  1980-11       Impact factor: 4.030

7.  A quantitative ultrastructural and biochemical analysis of the process of reinnervation of the superior cervical ganglion in the adult rat.

Authors:  G Raisman; P M Field; A J Ostberg; L L Iversen; R E Zigmond
Journal:  Brain Res       Date:  1974-05-10       Impact factor: 3.252

8.  Both nicotinic and muscarinic agonists acutely increase tyrosine 3-monooxygenase activity in the superior cervical ganglion.

Authors:  N Y Ip; R L Perlman; R E Zigmond
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

9.  Secretin and vasoactive intestinal peptide acutely increase tyrosine 3-monooxygenase in the rat superior cervical ganglion.

Authors:  N Y Ip; C K Ho; R E Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Activation of tyrosine 3-monooxygenase in pheochromocytoma cells by adenosine.

Authors:  R E Erny; M W Berezo; R L Perlman
Journal:  J Biol Chem       Date:  1981-02-10       Impact factor: 5.157

View more
  8 in total

Review 1.  Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse?

Authors:  Corey B Smith; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-05-18       Impact factor: 3.444

2.  The peptide VIP is a neurotransmitter in rat adrenal medulla: physiological role in controlling catecholamine secretion.

Authors:  T D Wakade; M A Blank; R K Malhotra; R Pourcho; A R Wakade
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

3.  Mechanisms mediating pituitary adenylate cyclase-activating polypeptide depolarization of rat sympathetic neurons.

Authors:  M M Beaudet; R L Parsons; K M Braas; V May
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

4.  Stimulation of the synthesis of catecholamines in a sympathetic ganglion via cholinergic and non-cholinergic mechanisms.

Authors:  N E Andén; M Grabowska-Andén; L Klaesson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

5.  Adrenocorticotropic hormone elevates gene expression for catecholamine biosynthesis in rat superior cervical ganglia and locus coeruleus by an adrenal independent mechanism.

Authors:  L I Serova; V Gueorguiev; S-Y Cheng; E L Sabban
Journal:  Neuroscience       Date:  2008-03-06       Impact factor: 3.590

6.  Electrical stimulation increases phosphorylation of tyrosine hydroxylase in superior cervical ganglion of rat.

Authors:  A L Cahill; R L Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

7.  Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury.

Authors:  R P Mohney; R E Zigmond
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 8.  PACAP signaling in stress: insights from the chromaffin cell.

Authors:  Lee E Eiden; Andrew C Emery; Limei Zhang; Corey B Smith
Journal:  Pflugers Arch       Date:  2017-09-30       Impact factor: 3.657

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.